Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Craig L Slingluff, Jr., MD
University of Virginia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Emory University
Atlanta, Georgia, United States
Recruiting - University of Maryland
Baltimore, Maryland, United States
Not, yet, recruiting - University of Michigan
Ann Arbor, Michigan, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Duke University Health System
Durham, North Carolina, United States
Recruiting - University of Pennsylvania
Philadelphia, Pennsylvania, United States
Not, yet, recruiting - Cancer Center at the University of Virginia
Charlottesville, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Sept 2023
- Primary completion
- 1 Sept 2028
- Completion
- 1 Sept 2028
- Last update posted
- 17 Sept 2025
- Registered enrollment
- 66
- Registry id
- NCT05839912
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.